NCT06658990

Brief Summary

To explore the effect of ultrasound positioning assisted buccal acupuncture on postoperative pain and recovery quality of patients undergoing thoracoscopic radical resection

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
136

participants targeted

Target at P50-P75 for not_applicable surgery

Timeline
Completed

Started Feb 2024

Shorter than P25 for not_applicable surgery

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2024

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

October 23, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 26, 2024

Completed
Last Updated

October 26, 2024

Status Verified

August 1, 2024

Enrollment Period

5 months

First QC Date

October 23, 2024

Last Update Submit

October 23, 2024

Conditions

Surgery

Outcome Measures

Primary Outcomes (1)

  • Number of additional analgesics

    7 days

Study Arms (2)

buccal acupuncture

EXPERIMENTAL
Procedure: buccal acupuncture

control

ACTIVE COMPARATOR
Drug: control

Interventions

buccal acupuncturePROCEDURE

ultrasound positioning assisted buccal acupuncture

buccal acupuncture
controlDRUG

Sufentanil is used after surgery

control

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Tracheal intubation under general anesthesia
  • Young and middle-aged patients aged 18-65 years
  • BMI: 18.5-28kg /m2

You may not qualify if:

  • head and facial trauma, infection, disease
  • more than 2 kinds of coronary heart disease, hypertension, stroke, diabetes, immune disease and other diseases before surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wang Mengyao

Yangzhou, Jiangsu, 225000, China

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 23, 2024

First Posted

October 26, 2024

Study Start

February 1, 2024

Primary Completion

June 30, 2024

Study Completion

June 30, 2024

Last Updated

October 26, 2024

Record last verified: 2024-08

Locations

CN(1)